If you have difficulty in submitting comments on draft standards you can use a commenting template and email it to admin.start@bsigroup.com. The commenting template can be found here.
This document will describe principles, methodological considerations and decision pathways for selecting and applying biofilm methods intended to support antibiofilm claims for products, materials and interventions.
It will:
Cover in vitro biofilm growth models, critical experimental variables, intervention testing approaches, sampling strategies, analysis methods and data interpretation.
Apply across healthcare, water, food, industrial and consumer product sectors.
It will not prescribe one universal method or provide regulatory pass–fail criteria, as these vary by sector and product type.
How will the Standard be used? How do users interact with the document, eg extract information? We would like to know how the Standard is being/will be used by the target audience so that we can identify any possibilities of developing other solutions. Users will engage with the document as a:
• Decision-making framework to identify which biofilm method types are appropriate for their application.
• Reference guide for experimental design, quality control, reporting and interpretation.
• Training and harmonisation tool for laboratories seeking to align practices.
• Supporting document in regulatory dossiers or product performance justifications.
Required form fields are indicated by an asterisk (*) character.
You are now following this standard. Weekly digest emails will be sent to update you on the following activities:
You can manage your follow preferences from your Account. Please check your mailbox junk folder if you don't receive the weekly email.
You have successfully unsubscribed from weekly updates for this standard.
Comment by: